Myeloperoxidase Inhibitor-I is a benzoic acid hydrazide analog acting as an irreversible and specific inhibitor of the peroxidation activity of MPO. Myeloperoxidase Inhibitor-I shows no effect in inhibition of catalase or glutathione peroxidase activities. Shows no effect on the production of superoxide by neutrophils. Shown to inhibit H2O2-induced apoptosis in HL-60.
Engelmann, I., et al. 2000. Redox Report 5, 207. Wagner, B.A., et al. 2000. J. Biol. Chem. 275, 22461. Burner, U., et al. 1999. J. Biol. Chem. 274, 9494. Kettle, A.J., et al. 1997. Biochem. J. 321, 503. Kettle, A.J., et al. 1995. Biochem. J. 308, 559.
Soluble in DMSO (10 mg/ml), dilute acids, and water (partly miscible).
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Download SDS (MSDS)
Certificate of Analysis
Adobe Acrobat Reader is required to reliably view, print and comment on PDF documents
bvseo_sdk, java_sdk, bvseo-3.2.0
CLOUD, getContent, 57ms
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
Wang Q; et alWang Q; et al. (PubMed ID: 25024373) determined that Myeloperoxidase Inhibitor-I prevented HFD-enhanced insulin resistance and decreased peroxidase activity of neutrophils. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn
Create a new account
Email address already exists, please enter a new valid email address.
USE YOUR SOCIAL NETWORK
Create an account quickly and easily with your preferred social network account. You won't have to remember an extra name and password.
Creating an account with us makes your shopping experience much easier and faster. You can save favorites, save cart, check order status and speed through checkout with saved addresses, payment methods and more.